These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 24122861)

  • 1. Epitope-optimized alpha-fetoprotein genetic vaccines prevent carcinogen-induced murine autochthonous hepatocellular carcinoma.
    Hong Y; Peng Y; Guo ZS; Guevara-Patino J; Pang J; Butterfield LH; Mivechi NF; Munn DH; Bartlett DL; He Y
    Hepatology; 2014 Apr; 59(4):1448-58. PubMed ID: 24122861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering α-fetoprotein-based gene vaccines to prevent and treat hepatocellular carcinoma: review and future prospects.
    He Y; Hong Y; Mizejewski GJ
    Immunotherapy; 2014; 6(6):725-36. PubMed ID: 25041030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alarmin augments the antitumor immunity of lentiviral vaccine in ectopic, orthotopic and autochthonous hepatocellular carcinoma mice.
    Liu Z; Lu Z; Jing R; Zuo B; Gao X; Han G; Qi H; Wu L; Liu Y; Yin H
    Theranostics; 2019; 9(14):4006-4018. PubMed ID: 31281528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha fetoprotein DNA prime and adenovirus boost immunization of two hepatocellular cancer patients.
    Butterfield LH; Economou JS; Gamblin TC; Geller DA
    J Transl Med; 2014 Apr; 12():86. PubMed ID: 24708667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendritic cell-derived exosomes elicit tumor regression in autochthonous hepatocellular carcinoma mouse models.
    Lu Z; Zuo B; Jing R; Gao X; Rao Q; Liu Z; Qi H; Guo H; Yin H
    J Hepatol; 2017 Oct; 67(4):739-748. PubMed ID: 28549917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lentivirally engineered dendritic cells activate AFP-specific T cells which inhibit hepatocellular carcinoma growth in vitro and in vivo.
    Liu Y; Butterfield LH; Fu X; Song Z; Zhang X; Lu C; Ding G; Wu M
    Int J Oncol; 2011 Jul; 39(1):245-53. PubMed ID: 21491085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of α-fetoprotein-specific T-cell receptors for hepatocellular carcinoma immunotherapy.
    Zhu W; Peng Y; Wang L; Hong Y; Jiang X; Li Q; Liu H; Huang L; Wu J; Celis E; Merchen T; Kruse E; He Y
    Hepatology; 2018 Aug; 68(2):574-589. PubMed ID: 29443377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of AFP vaccine and immune checkpoint inhibitors slows hepatocellular carcinoma progression in preclinical models.
    Lu X; Deng S; Xu J; Green BL; Zhang H; Cui G; Zhou Y; Zhang Y; Xu H; Zhang F; Mao R; Zhong S; Cramer T; Evert M; Calvisi DF; He Y; Liu C; Chen X
    J Clin Invest; 2023 Jun; 133(11):. PubMed ID: 37040183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [DNA vaccine encoding alpha-fetoprotein with fused ornithine decarboxylase degradation signal significantly suppresses hepatocellular carcinoma growth in mice].
    Morozov AV; Morozov VA; Astakhova TM; Timofeev AV; Karpov VL
    Mol Biol (Mosk); 2012; 46(3):434-51. PubMed ID: 22888633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. alpha-Fetoprotein-specific tumor immunity induced by plasmid prime-adenovirus boost genetic vaccination.
    Meng WS; Butterfield LH; Ribas A; Dissette VB; Heller JB; Miranda GA; Glaspy JA; McBride WH; Economou JS
    Cancer Res; 2001 Dec; 61(24):8782-6. PubMed ID: 11751399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy of hepatocellular carcinoma with a vaccine based on xenogeneic homologous alpha fetoprotein in mice.
    Zhang W; Liu J; Wu Y; Xiao F; Wang Y; Wang R; Yang H; Wang G; Yang J; Deng H; Li J; Wen Y; Wei Y
    Biochem Biophys Res Commun; 2008 Nov; 376(1):10-4. PubMed ID: 18725206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Research progress of alpha-fetoprotein vaccine in hepatocellular carcinoma].
    Cheng LL; Chen BD; Zhao GZ
    Zhonghua Gan Zang Bing Za Zhi; 2020 Feb; 28(2):183-187. PubMed ID: 32164075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hierarchy of alpha fetoprotein (AFP)-specific T cell responses in subjects with AFP-positive hepatocellular cancer.
    Liu Y; Daley S; Evdokimova VN; Zdobinski DD; Potter DM; Butterfield LH
    J Immunol; 2006 Jul; 177(1):712-21. PubMed ID: 16785570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha fetoprotein is more than a hepatocellular cancer biomarker: from spontaneous immune response in cancer patients to the development of an AFP-based cancer vaccine.
    Bei R; Mizejewski GJ
    Curr Mol Med; 2011 Oct; 11(7):564-81. PubMed ID: 21707514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AFP-specific immunotherapy impairs growth of autochthonous hepatocellular carcinoma in mice.
    Cany J; Barteau B; Tran L; Gauttier V; Archambeaud I; Couty JP; Turlin B; Pitard B; Vassaux G; Ferry N; Conchon S
    J Hepatol; 2011 Jan; 54(1):115-21. PubMed ID: 20961645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive analysis of the alpha-fetoprotein-specific CD8+ T cell responses in patients with hepatocellular carcinoma.
    Thimme R; Neagu M; Boettler T; Neumann-Haefelin C; Kersting N; Geissler M; Makowiec F; Obermaier R; Hopt UT; Blum HE; Spangenberg HC
    Hepatology; 2008 Dec; 48(6):1821-33. PubMed ID: 19003875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An attenuated Salmonella oral DNA vaccine prevents the growth of hepatocellular carcinoma and colon cancer that express alpha-fetoprotein.
    Chou CK; Hung JY; Liu JC; Chen CT; Hung MC
    Cancer Gene Ther; 2006 Aug; 13(8):746-52. PubMed ID: 16410824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific antitumor immunity induced by cross-linking complex heat shock protein 72 and alpha-fetoprotein.
    Wang XP; Lin HP; Wang QX; Gu Y
    Cancer Biother Radiopharm; 2012 Apr; 27(3):189-97. PubMed ID: 22372558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro.
    Cao DY; Yang JY; Dou KF; Ma LY; Teng ZH
    Hum Immunol; 2007 May; 68(5):334-41. PubMed ID: 17462500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of ex vivo peripheral and intrahepatic α-fetoprotein-specific CD4+ responses in hepatocellular carcinoma.
    Witkowski M; Spangenberg HC; Neumann-Haefelin C; Büttner N; Breous E; Kersting N; Drognitz O; Hopt UT; Blum HE; Semmo N; Thimme R
    Int J Cancer; 2011 Nov; 129(9):2171-82. PubMed ID: 21170957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.